Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2021

Oct 20, 2021

SELL
$67.69 - $73.03 $4,873 - $5,258
-72 Closed
0 $0
Q2 2021

Jul 23, 2021

BUY
$63.47 - $69.35 $4,569 - $4,993
72 New
72 $5,000
Q1 2020

May 07, 2020

SELL
$62.63 - $80.22 $3,131 - $4,011
-50 Closed
0 $0
Q3 2019

Oct 22, 2019

BUY
$62.51 - $69.0 $3,125 - $3,450
50 New
50 $3,000

Others Institutions Holding GILD

About GILEAD SCIENCES, INC.


  • Ticker GILD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,253,369,984
  • Market Cap $83.6B
  • Description
  • Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...
More about GILD
Track This Portfolio

Track Personal Wealth Partners Portfolio

Follow Personal Wealth Partners and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Personal Wealth Partners, based on Form 13F filings with the SEC.

News

Stay updated on Personal Wealth Partners with notifications on news.